# NIH HVTN 302: Three mRNA HIV Vaccines Clinical Trial

**ID:** VAX-003
**Year:** 2024
**Source:** NIH
**Link:** [https://www.nih.gov/news-events/news-releases/nih-launches-clinical-trial-three-mrna-hiv-vaccines](https://www.nih.gov/news-events/news-releases/nih-launches-clinical-trial-three-mrna-hiv-vaccines)

---

## Abstract

NIAID Phase 1 trial evaluating three experimental mRNA-based HIV vaccines for safety and immunogenicity.

---

## Key Concepts

- Primary research focus from 2023-2025 HIV literature
- Relevant to understanding HIV biology, treatment, or prevention
- Contributes to the broader HIV research landscape

---

## Relevance to Project

This paper contributes to the Ternary VAE bioinformatics project by providing context on:
- HIV sequence evolution and variability
- Biological constraints on viral fitness
- Therapeutic targets and resistance mechanisms

---

*Added: 2025-12-24*
